Shieldworkz Expands OT Cybersecurity Offerings to Tackle Emerging Threats and Posture Management Needs
ABU DHABI , UAE and BANGALORE, India , May 23, 2025 /PRNewswire/ — Shieldworkz, a leading cybersecurity innovator, today announced the expansion of its Cyber-Physical System security offerings. This strategic move addresses the evolving threat landscape, increasing regulatory compliance obligations, and growing demand for proactive security posture management across industries.
The expanded portfolio focuses on enhanced AI-powered risk and gap assessment, automated exposure and cyber risk management, and security posture optimization—enabling enterprises to stay ahead of sophisticated cyber threats and regulatory expectations. Shieldworkz has been working with leading enterprises and governments around the world to secure their critical systems through its comprehensive suite of services.
With this move, Shieldworkz reinforces its OT security leadership while strengthening its commitment to delivering end-to-end OT security solutions.
Kiran Zachariah , CEO Shieldworkz:
'Cyber threats are evolving faster than ever, and so must the way we defend against them. Our expanded OT security offerings are designed to give organizations the insights and control they need to proactively manage cyber risk—not just react to it. We're bridging the gap between visibility and action.'
About Shieldworkz
Shieldworkz (Shieldworks OT Systems) is a leading cybersecurity firm specializing in safeguarding cyber-physical systems (CPS) across industries such as utilities, oil and gas, airports, ports, manufacturing, mining and smart cities. Leveraging proprietary technologies, unmatched OT security services portfolio, SOC offering (including SOCaas) and a robust consulting platform, Shieldworkz enables businesses to secure their infrastructure.
Shieldworkz' offerings align with global frameworks, regulatory mandates and standards such as IEC 62443, NIST CSF, NIS2 , NCA OTCC, MITRE ATT&CK® and Zero Trust architectures. These offerings include advanced managed security service offerings, automated risk and exposure management, and AI-driven security posture optimization, enabling enterprises to proactively manage cyber risks.
With a commitment to delivering end-to-end security offerings, Shieldworkz empowers security teams to gain real-time visibility, reduce risk, comply with global standards and strengthen resilience.
For more information, visit: https://shieldworkz.com Download OT security compliance kits here
Access the latest OT Security Threat Landscape Report here.
Connect with us on social media:LinkedInTwitter
YouTube
Logo: https://mma.prnewswire.com/media/2694121/Shieldworkz_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/shieldworkz-expands-ot-cybersecurity-offerings-to-tackle-emerging-threats-and-posture-management-needs-302463181.html
Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Business Upturn takes no editorial responsibility for the same.
PR Newswire is a distributor of press releases headquartered in New York City.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Biologic Therapeutics Market to Hit $794.5 Billion by 2029
"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative Vaccines" BOSTON, July 28, 2025 /PRNewswire/ -- According to the latest study from BCC Research, "Biologic Therapeutic Drugs: Technologies and Global Markets" is projected to increase from $499.2 billion in 2024 to reach $794.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029. This report provides a comprehensive analysis of the global market for biologic therapeutic drugs, segmented by product type (such as mAbs vaccines, and cell and gene therapies), source (mammalian, microbial, others), application (oncology, autoimmune, and infectious diseases), and region (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). It explores key market trends, challenges, and ESG developments, and examines the emerging technologies shaping the industry. The report also includes a competitive landscape analysis with market share rankings and detailed profiles of leading companies. This report is particularly relevant now due to the growing demand for innovative therapies and the rapid advances in regenerative medicine. Increased investments and intensified research activities are accelerating the development of biologic drugs, while a surge in product approvals is expanding treatment options in many medical fields. These factors are collectively driving significant growth in the biologics market, making timely insights into trends, challenges, and competitive dynamics more critical than ever. The factors driving the market's growth include: Growing Demand for Biologics: Biologics are increasingly favored due to their high efficacy, targeted action, and ability to treat complex diseases like cancer and autoimmune disorders. Patients and healthcare providers are turning to these advanced therapies for better outcomes and fewer side effects. Rising Investments in Biopharmaceuticals: The biopharma sector is seeing a surge in funding from pharmaceutical companies, investors, and governments. These investments support research, clinical trials, and manufacturing infrastructure, accelerating the development and availability of biologic drugs. Product Development Collaborations and Agreements: Collaborations between biotech firms and large pharmaceutical companies are common, enabling shared expertise, reduced costs, and faster product development. Licensing deals and joint ventures also help expand market reach and streamline commercialization. Transition Toward Personalized Medicines: Biologics are central to the shift toward personalized medicine, where treatments are tailored to individual genetic profiles. Advances in genomics and diagnostics enable more precise therapies, reducing trial-and-error in treatment. Aging Population and the Prevalence of Chronic Diseases: An aging global population is leading to a higher incidence of chronic diseases such as diabetes, cancer, and arthritis. Biologics offer effective long-term treatment options for these conditions, making them essential in managing the health needs of older adults. Request a sample copy of the global market for biologic therapeutic drugs report. Report Synopsis Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $456.9 billion Market size forecast $794.5 billion Growth rate CAGR of 9.7% for the forecast period of 2024-2029 Segments covered Type, Source, Application, Region Regions covered North America, Europe, Asia-Pacific, Rest of the World(South America and the Middle East and Africa). Countries covered U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy,China, India, Japan, Australia. Market drivers Growing Demand for Biologics Rising Investments in Biopharmaceuticals Product Development Collaborations andAgreements Transition Toward Personalized Medicines Rising Aging Population and the Growing Prevalenceof Chronic Diseases Interesting facts: The biologic therapeutics market is witnessing higher number of approvals for several new therapies and an increase in biologics approvals yearly. In 2023, the market witnessed approvals for breakthrough therapies such as gene editing therapy Casgevy from CRISPR Therapeutics and Vertex Pharmaceuticals and Leqembi (lecanemab) from Eisai for Alzheimer's disease. Emerging startups Arcus Biosciences Allogene Therapeutics Astria Therapeutics Bean Therapeutics HiFiBiO Therapeutics The report addresses the following questions: 1. What is the projected size and growth rate of the market? The global market for biologic therapeutic drugs was valued at $456.9 billion in 2023 and is expected to grow at a CAGR of 9.7% from 2024 to 2029 to reach $794.5 billion by the end of 2029. 2. What factors are driving the growth of the market? The global market for biologics therapeutic drugs is growing due to the world's rising aging population and the growing prevalence of chronic diseases, increasing numbers of product launches, and high demand for personalized medicine. 3. Which market segments are covered in the report? The global market for biologics therapeutic drugs is segmented based on product type, source, application, and region. 4. Which product type segment will be dominant through 2029? The monoclonal antibodies (mAbs) segment will dominate the market through 2029. 5. Which region has the largest market share? North America holds the largest share of the market. Market leaders include: ABBVIE INC. AMGEN INC. ASTRAZENECA BRISTOL-MYERS SQUIBB CO. ELI LILLY AND CO. F. HOFFMANN-LA ROCHE LTD. GILEAD SCIENCES INC. GSK PLC. JOHNSON & JOHNSON SERVICES INC. MERCK & CO. INC. NOVARTIS AG NOVO NORDISK A/S PFIZER INC. REGENERON PHARMACEUTICALS INC. SANOFI Related reports: Antibody Drugs: Technologies and Global Markets: This report provides reviews the global antibody drug market, focusing on monoclonal antibodies (mAbs) used in treating chronic diseases like cancer and autoimmune disorders. It covers market trends, regional analysis, and key companies. Forecasts extend to 2029, highlighting growth in therapeutic applications and technological advances. Purchase a copy of the report direct from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. Contact Us Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA Email: info@ Phone: +1 781-489-7301 For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Logo - View original content to download multimedia: SOURCE BCC Research LLC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
InventHelp Inventor Develops Effective Shark Repellent (SBT-2039)
PITTSBURGH, July 28, 2025 /PRNewswire/ -- "I wanted to create a way to protect individuals who engage in water sports in the ocean from shark attacks," said an inventor, from Soquel, Calif., "so I invented THE ORCA. My design increases safety and it would not hinder your movements while swimming, snorkeling, or scuba diving." The patent-pending invention provides an effective shark repellent for ocean-sports enthusiasts. In doing so, it would prompt sharks in the vicinity to vacate the area. As a result, it increases safety, and it helps reduce the risk of shark attacks. The invention features a compact design that is easy to use so it is ideal for surfers and other ocean/water-sports enthusiasts. The original design was submitted to the San Diego sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 24-SBT-2039, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at View original content to download multimedia: SOURCE InventHelp Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
Info-Tech Research Group Extends Annual Awards Nomination Deadlines as Recognition Program For IT Leadership Grows
Info-Tech Research Group has extended the nomination deadline for two categories in its annual awards program that celebrates excellence across the evolving landscape of IT leadership: Innovator of the Year and Women Leading IT. In its recently expanded format for 2025, the Info-Tech Awards recognize both individuals and organizations that are driving measurable outcomes through strategic alignment, innovation, and operational impact. TORONTO, July 28, 2025 /PRNewswire/ - Info-Tech Research Group, a global IT research and advisory firm, has extended the nomination deadline for two of its 2025 Info-Tech Awards categories: Innovator of the Year and Women Leading IT. Due to increased demand and interest, nominations for these two categories will now be accepted until August 31, 2025, as applicants showcase leadership, innovation, and measurable impact in the field of IT. In an expanded format of the firm's annual awards program that now includes a total of five new award categories, the Info-Tech Awards are designed to spotlight leaders and organizations that go beyond operational delivery to create strategic value. Through a mix of data from Info-Tech's CIO Business Vision diagnostic, nomination materials, and expert evaluation, the program ensures that recipients are recognized not only for their accomplishments but also for the impact they've had across their organizations and industries over the past year. "We've seen firsthand how technology leaders are elevating their organizations, not just through IT excellence, but by driving real and measurable value," says Geraldine Mongay Vignau, Vice President of Customer Marketing at Info-Tech Research Group. "The Info-Tech Awards were expanded to reflect this shift, recognizing not just titles or projects, but lasting, measurable impact across the organization and the people and teams who are redefining what IT leadership looks like." Info-Tech Awards 2025 Categories Applications Due August 31, 2025 Innovator of the Year Award – An organization that has implemented groundbreaking IT initiatives, used technology in innovative ways, or has set new industry standards that are shaping the future of IT. Women Leading IT Award – IT professionals who exemplify innovation, inclusive leadership, and mentorship within their organizations and the broader industry, inspiring the next generation of women. Spotlighting Award-Winning IT Leaders at Info-Tech LIVE 2025 in Las Vegas As part of Info-Tech LIVE 2025 in Las Vegas, a standout panel session titled Lessons From Exceptional IT Leaders brought together past award recipients from various sectors, including higher education, healthcare, public health, and manufacturing. Moderated by Geoff Nielson, Senior Vice President at Info-Tech Research Group, the discussion highlighted practical strategies for driving stakeholder satisfaction, leading transformation, and earning organizational trust. The expert panel included the following IT leaders and previous honorees: Isaac Abbs, Assistant Vice Chancellor for Information Technology and Chief Information Officer at Pima Community College Jason Frame, Chief Information Officer for Southern Nevada Health District Jamie Hornstein, North America CIO for ProDriven Global Brands Bharath Prabhakaran, Vice President and Chief Digital Officer at the University of Cincinnati "The most important thing IT leaders can do is measure stakeholder satisfaction and act on the feedback," said Nielson during the session on June 12, 2025. "It's a privilege to recognize two sets of leaders this year: those who were scored highest by stakeholders via Info-Tech's CIO Business Vision program as well as those nominated for their vision and impact in the industry." Panelists shared candid insights into how they built trust, scaled innovation, and delivered results, from implementing AI solutions and addressing technical debt to launching campus-wide infrastructure upgrades and redefining career pathways. During the session, the speakers also shared how they operationalized feedback from Info-Tech's CIO Business Vision survey, using it not only to measure satisfaction but to guide concrete actions and continuous improvements across their teams. Key Dates and Application Process Nomination Deadline: Nominations for the Innovator of the Year and Women Leading IT categories will close on August 31, 2025. Selection Process: Winners will be selected through a combination of diagnostic data, nomination forms, and interviews, with additional evaluations as required. Announcement & Recognition: Awards will be publicly announced in November 2025, with winners receiving a trophy and certificate to recognize their achievements. For full eligibility criteria and submission details, as well as detailed information about each of the awards, please visit the Info-Tech Awards 2025 page. To stay up to date with all further announcements, please follow Info-Tech Research Group on LinkedIn and X. About Info-Tech Research Group Info-Tech Research Group is one of the world's leading research and advisory firms, proudly serving over 30,000 professionals. The company produces unbiased, highly relevant research and provides advisory services to help leaders make strategic, timely, and well-informed decisions. For nearly 30 years, Info-Tech has partnered closely with teams to provide them with everything they need, from actionable tools to analyst guidance, ensuring they deliver measurable results for their organizations. To learn more about Info-Tech's divisions, visit McLean & Company for HR research and advisory services and SoftwareReviews for software-buying insights. Media professionals can register for unrestricted access to research across IT, HR, and software, and hundreds of industry analysts through the firm's Media Insiders program. To gain access, contact pr@ View original content to download multimedia: SOURCE Info-Tech Research Group Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
